Clinical trial · Observational
Vascular CT Assessment of Structural Autograft and Allograft Healing
NCT00594776CI-TRIAL-00020836completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine the ability of a cone beam CT to measure bone healing.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bone Tumors | Bone Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cone Beam CT Scan | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- 1
- description
- Patients who have received a structrual allograft or vascularized fibular autograft surgery to reconstruct their tibia, femur, ulna/radius or humerus for treatment of a bone tumor.
- interventionNames
- Device: Cone Beam CT Scan
Primary outcomes (1)
- measure
- Change in intramedullary vascular volume and new bone growth based on CBCT
- timeFrame
- 2, 8 & 18 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 10 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * male or female * all races will be included * autograft or allograft of long bone as part of treatment for bone tumor Exclusion Criteria: * pregnancy * patients with a history of IV contrast reactions * contraindication to use of epinephrine or diphenhydramine * hypertyroidism or history of sensitivity to iodine * kidney disease (abnormal urinalysis or calculaged GFR) or poor hydration due to poor intake or other causes
References
Publications (0)
Data not yet available
No reference posted for this study.